ARCHIVES

In Brief: House Cuts NCI Rescission To $7.73 Million; Weinhuse, Ultmann New ACCR, ASCO Presidents

This article is from The Cancer Letter archive.

Vol. 07 No. 19 | May 8, 1981

Download PDF Visit The Full Archive

Related Articles

AGS-003 Immunotherapy Induces T Cell Responses in Phase II Trial

November 29, 2013

In Brief: Blumberg, Comis, Skalka Named Fox Chase VPs; Howard Temin Appointed To NCAB

June 5, 1987

FDA Approves Generic Oncology Injectable Currently In Shortage

September 27, 2013

Alan Rabson Outlasts Them All, Even His Bosses, As DCBD Chief

January 15, 1982

Lederberg Appointment As Panel Chairman Confirmed; Bernard Fisher will Be Names To The Other Vacancy

November 30, 1979

NCI Says More Phase Trials Needed In Cancer Prevention, Nutrition

April 18, 1986